Your browser doesn't support javascript.
loading
Developing and Validating a Clinical Warfarin Dose-Initiation Model for Black-African Patients in South Africa and Uganda.
Asiimwe, Innocent G; Waitt, Catriona; Sekaggya-Wiltshire, Christine; Hutchinson, Claire; Okello, Emmy; Zhang, Eunice J; Semakula, Jerome R; Mouton, Johannes P; Cohen, Karen; Blockman, Marc; Lamorde, Mohammed; Jorgensen, Andrea L; Pirmohamed, Munir.
Afiliação
  • Asiimwe IG; The Wolfson Centre for Personalized Medicine and MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK.
  • Waitt C; The Wolfson Centre for Personalized Medicine and MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK.
  • Sekaggya-Wiltshire C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Hutchinson C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Okello E; The Wolfson Centre for Personalized Medicine and MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK.
  • Zhang EJ; Uganda Heart Institute, Kampala, Uganda.
  • Semakula JR; The Wolfson Centre for Personalized Medicine and MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK.
  • Mouton JP; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Cohen K; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Blockman M; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Lamorde M; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Jorgensen AL; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Pirmohamed M; Department of Biostatistics, Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.
Clin Pharmacol Ther ; 109(6): 1564-1574, 2021 06.
Article em En | MEDLINE | ID: mdl-33280090
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Varfarina / População Negra Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Varfarina / População Negra Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido